Environmental Risk Assessment Preparation for Pharmaceuticals
Synthesize pharmaceutical environmental data into FDA-compliant risk assessments
What You Can Do
This skill helps you synthesize complex environmental toxicology and fate data into cohesive, regulatory-quality Environmental Assessment narratives. You can organize hazard identification, exposure assessment, and risk characterization frameworks; integrate multi-study ecotoxicity evidence; cross-reference FDA/EMA/ICH M7 guidance; and identify data gaps—all while maintaining scientific rigor and compliance consistency required for NDAs, INDs, and BPCIs.
Features
Organizes data flow from hazard identification through exposure assessment to risk characterization
Consolidates ecotoxicity test results, environmental fate studies, and monitoring data into consistent narratives
Cross-references ICH M7, FDA Environmental Assessment Guidance, and EMA CHMP criteria to ensure section completeness
Drafts scientifically-grounded rationales for acute/chronic toxicity, persistence, and bioaccumulation classifications
Structures predicted environmental concentration (PEC) scenarios and exposure pathways into assessment narratives
Flags missing studies, inadequate biodegradation data, or exposure uncertainties requiring follow-up work
Links individual ecotoxicity reports and environmental monitoring results to specific EA sections with proper terminology
Example Output
Input: Raw data including fish acute toxicity (96-h LC₅₀), Daphnia chronic toxicity (21-d NOEC), soil biodegradation study (% mineralization at 28 days), LogPow, and predicted aquatic PEC from wastewater treatment.
Output Example 1 — Hazard Characterization Section: "The aquatic hazard profile was determined based on acute and chronic ecotoxicity studies in three trophic levels. Fish (Danio rerio) acute LC₅₀ of 2.3 mg/L and Daphnia magna 21-day NOEC of 0.15 mg/L indicate Category 1 acute aquatic hazard (meets ≤1 mg/L criterion). Chronic classification is Category 1 based on the NOEC/toxicity ratio to hazard thresholds per GHS Annex 1.A. Ready biodegradability testing showed 38% mineralization at 28 days, indicating non-rapid degradation and persistence concern."
Output Example 2 — Risk Characterization: "Environmental risk is low in aquatic compartments under predicted exposure scenarios. Predicted PEC in surface water (0.08 μg/L) derived from wastewater treatment plant modeling yields PEC/PNEC ratio of 0.002, indicating negligible acute risk. Bioaccumulation potential is limited (BCF <100, Log Kow 1.8), and terrestrial exposure pathways are not expected due to low soil mobility and rapid aqueous phase degradation."
What's Included
- SKILL.md: Full environmental risk assessment protocol with compliance frameworks
- EA Outline Template: Section-by-section structure for NDAs/INDs/BPCIs following FDA guidance
- Ecotoxicity Data Synthesis Checklist: Ensures all relevant studies (fish, Daphnia, algae, bacteria) are integrated
- ICH M7 Cross-Reference Table: Maps assessment elements to specific guideline requirements
- Hazard Classification Justification Framework: Structured format for GHS category rationales with threshold documentation
Who It's For
- Pharmaceutical toxicologists drafting Environmental Assessments for regulatory submissions
- Regulatory affairs professionals preparing NDA/IND environmental chapters
- Pre-clinical/safety scientists synthesizing ecotoxicity study data
- Environmental consultants supporting pharmaceutical companies in EA development
- Quality assurance reviewers validating Environmental Assessment completeness and consistency
Best For
- Organizing and structuring multi-study ecotoxicity datasets into coherent assessment narratives
- Drafting environmental chapters for FDA/EMA submissions with regulatory language and citations
- Synthesizing evidence for aquatic hazard classification and bioaccumulation assessments
- Identifying data gaps and recommending follow-up environmental studies
- Cross-referencing pharmaceutical environmental data against ICH M7 and FDA guidance requirements
You might also like
Systematically evaluate ingredient compatibility against your active pharmaceutical ingredients, predict formulation behavior and stability risks, and troubleshoot phase separation, incompatibility, and irritation issues in real time. Generate ICH-aligned stability protocols, excipient safety summaries, and regulatory-ready documentation that accelerates IND, NDA, and ANDA submissions without replacing lab validation.
by kody-w
This skill generates comprehensive fault study reports, protection coordination analyses, and compliance documentation for electrical power systems. It systematically documents fault scenarios, relay settings, coordination curves, and technical specifications required for grid operations and regulatory compliance. You produce production-ready documentation that meets industry standards—IEEE, NERC, and regional RTO requirements.
by kody-w
You consolidate parallel data streams from preclinical toxicology studies (clinical pathology, histopathology, body weight changes, organ weights, clinical observations, mortality) into coherent regulatory-compliant narratives. This skill synthesizes findings across 6–12 endpoints simultaneously, identifies NOAEL/LOAEL with biological justification, determines safety margins, interprets species-specific or sex-specific signals, and produces Results & Discussion sections that satisfy FDA/EMA reviewers while supporting appropriate dosing decisions for IND-enabling studies.
by kody-w
Analyze your PLC code and ladder logic to identify logic errors, safety violations, and inefficiencies before they reach production. You'll get detailed diagnostics of control system failures, safety compliance verification against IEC 61131 standards, and optimization recommendations for automation sequences. This skill helps you prevent costly downtime, ensure worker safety, and improve system performance across manufacturing operations.
by kody-w
Create comprehensive tool specifications tailored to your manufacturing process, material combinations, and performance requirements. Analyze cutting speeds, feeds, tool life, and thermal behavior to predict tool performance and identify optimization opportunities. You can compare design alternatives, predict failure modes, and generate compliance documentation for production tooling decisions.
by kody-w
You can prepare complete site monitoring visit documentation, including source document verification (SDV) checklists tailored to specific case report forms, comprehensive findings reports from visit notes, and structured data query forms for identified discrepancies. This skill standardizes compliance documentation, identifies protocol deviations systematically, and creates actionable remediation plans to maintain data integrity and GCP compliance across investigator sites.
by kody-w
This skill systematically analyzes your product designs to identify manufacturability issues early, saving costly revisions and manufacturing delays. It evaluates geometry, material selection, tolerances, assembly feasibility, and production process constraints. You get actionable feedback on cost drivers, process risks, and design optimizations before committing to production.
by kody-w
This skill analyzes CAD models and FEA results to identify design inefficiencies, stress concentrations, and manufacturing constraints. Claude provides actionable optimization recommendations, material substitutions, and cost-benefit trade-offs to accelerate your design iteration cycles. From concept review to final refinement, you get expert-level design feedback in seconds.
by kody-w